Thinking of joining a study?

Register your interest

Become a volunteer?

Clinical trials

2615 results

Sort By:

Effect of Daily Intake of Gazpacho on Semen Quality and Oxidative Stress

Study ID: NCT07375238
Start Date: 2026-03-01
End Date: 2029-09-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

80

Intervention / Treatment

Standardized Mediterranean Diet

Gazpacho

Sponsor

Ginefiv

Source: clinicaltrials.gov

Share:
Add to list

iCanQuit Smoking Cessation Among Hispanic Adults

Study ID: NCT06811038
Start Date: 2026-03-01
End Date: 2030-07-01
Study Type

Interventional

Study Phase

Phase3

No. of Participants

854

Intervention / Treatment

iCanQuit Smartphone App Smoking Cessation Program

Nicotine Gum

Nicotine Patch

Nicotine Lozenge

Survey Administration

Interview

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Randomization for the Identification of Best Treatment Intensity for Less Fit Adults With Acute Myeloid Leukemia and Myeloid Neoplasms

Study ID: NCT07094750
Start Date: 2026-03-01
End Date: 2029-06-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

50

Intervention / Treatment

Biospecimen Collection

Bone Marrow Collection

Electronic Health Record Review

Administration Questionnaire

Sponsor

Fred Hutchinson Cancer Center

Source: clinicaltrials.gov

Share:
Add to list

Consolidative Metastasis and Primary Directed Therapy (MPDT) for Renal Cell Carcinoma (RCC)

Study ID: NCT06770855
Start Date: 2026-04-11
End Date: 2028-09
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

23

Intervention / Treatment

Total consolidative MPDT

Sponsor

Abramson Cancer Center at Penn Medicine

Source: clinicaltrials.gov

Share:
Add to list

Neuropathic Pain Intervention With tDCS in Brazilian Military Personnel (NeuBRAIN Trial)

Study ID: NCT06994390
Start Date: 2026-03-01
End Date: 2030-03-01
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

120

Intervention / Treatment

tDCS

sham intervention

Sponsor

Goiás Military Police Hospital

Source: clinicaltrials.gov

Share:
Add to list

Venetoclax or Placebo in Combination With Reduced-Intensity Conditioning Hematopoietic Cell (Bone Marrow/Blood Stem Cell) Transplant and as Maintenance Therapy After Transplant in Patients With Acute Myeloid Leukemia (A MyeloMATCH Treatment Trial)

Study ID: NCT06954987
Start Date: 2026-03-18
End Date: 2028-05-15
Study Type

Interventional

Study Phase

Phase2

No. of Participants

244

Intervention / Treatment

Allogeneic Hematopoietic Stem Cell Transplantation

Biospecimen Collection

Bone Marrow Biopsy

Busulfan

Chest Radiography

Computed Tomography

Echocardiography Test

Fludarabine

Melphalan

Multigated Acquisition Scan

Placebo Administration

Positron Emission Tomography

Total-Body Irradiation

Venetoclax

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list

Prevention Programme for Improvement of Well-being and Level of Participation in Adolescents With Enhanced Psychiatric Burden in the School Environment.

Study ID: NCT06390384
Start Date: 2026-08-01
End Date: 2028-12-31
Study Type

Interventional

Study Phase

Not Applicable

No. of Participants

100

Intervention / Treatment

blinded-care counselling

App STEPS

digital and mental literacy training

Sponsor

RWTH Aachen University

Source: clinicaltrials.gov

Share:
Add to list

Study of AGN-151607-DP to Assess Adverse Events and Change in Disease Activity in Adult Participants Undergoing Open Abdominal Ventral Hernia Repair

Study ID: NCT07226791
Start Date: 2026-02-28
End Date: 2030-05
Study Type

Interventional

Study Phase

Phase2

No. of Participants

200

Intervention / Treatment

AGN-151607-DP

Placebo for AGN-151607-DP

Sponsor

AbbVie

Source: clinicaltrials.gov

Share:
Add to list

Long-term Study to Evaluate Safety and Persistence of GF-CART01

Study ID: NCT06985576
Start Date: 2026-05
End Date: 2041-05
Study Type

Observational

Study Phase

Not Applicable

No. of Participants

18

Intervention / Treatment
Sponsor

GenomeFrontier Therapeutics TW Co., Ltd.

Source: clinicaltrials.gov

Share:
Add to list

Testing the Addition of an Anti-cancer Drug, Abemaciclib, to the Usual Chemotherapy Treatment (Gemcitabine) for Soft Tissue Sarcoma

Study ID: NCT06498648
Start Date: 2026-04-12
End Date: 2027-01-31
Study Type

Interventional

Study Phase

Phase2

No. of Participants

74

Intervention / Treatment

Abemaciclib

Biopsy Procedure

Biospecimen Collection

Computed Tomography

Docetaxel

Fluorothymidine F-18

Gemcitabine

Positron Emission Tomography

Sponsor

National Cancer Institute (NCI)

Source: clinicaltrials.gov

Share:
Add to list